Original Article ert MTB/RIF in pediatric tuberculosis.
ert MTB/RIF in pediatric tuberculosis.
Abstract
Objective
To study the usefulness of Xpert TB/Rif in diagnosis of childhood tuberculosis in India.
Methods
Prospective study was including children from 1 month to 18 years of age with clinical suspicion of tuberculosis. All cases were classified as pulmonary and extra pulmonary tuberculosis based on symptoms. All children under 5 years of age underwent mantoux test. Imaging was done based on symptoms. Appropriate specimens were tested for smear microscopy, Xpert MTB/RIF, and liquid culture.
Results
In cases with a clinical diagnosis, microscopy had a sensitivity of 37.3% (CI-17.2% to 59.3%) and specificity of 100% (71.5%-100%), Xpert MTB/RIF had a sensitivity of 75% (CI- 55.1% to 89.3%) and a specificity of 100% (CI- 75.2% to 100%) while MGIT had a sensitivity of 68.2 % (CI- 51.9% to 81.8%) and specificity of 100% (CI- 75.2% to 100%).
In culture positive cases of pulmonary TB, microscopy had a sensitivity of 42.2% (CI-17.6% to 71.1%)and specificity of 75.0% (CI-34.8% to 96.8%) while Xpert MTB/RIF had a sensitivity and specificity of 78.5% (CI-49.2 to 95.3%) and 47.6% (CI-21.2%-73.4%) respectively. Xpert MTB/RIF had 100% sensitivity for detection of rifampicin resistance. Resistance to moxifloxacin was noted in 78% (11/14) while ofloxacin was resistant in 50% of the isolates (7/14).
Conclusions
With the availability of sensitive tests like Xpert MTB/RIF, paucibacillary disease in children can no longer be an excuse to start empiric anti tubercular drugs. With high levels of resistance for first and second line drugs Xpert MTB/RIF may not yet replace traditional cultures and drug sensitivity.
References
ANNEX 2 Country profiles for 30 high tb burden countries, 20 high TB burden countries based on absolute number of incident cases 10 high TB burden countries based on severity of disease burden (incidence per capita). Available from: www.who.int/tb/data
Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. 2013Available from: www.who.int
Definitions and reporting framework for tuberculosis-2013 revision. Available from:http://apps.who.int/iris/bitstream/handle/10665/79199/9789241505345_eng.pdf?sequence=1
Alvarez-Uria G, Azcona JM, Midde M, Naik PK, Reddy S, Reddy R. Rapid Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in HIV-Infected Patients. Comparison of LED Fluorescent Microscopy and the GeneXpert MTB/RIF Assay in a District Hospital in India. Tuberc Res Treat.2012;2012:1–4.
Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011;377(9776):1495–505.
Annual Reports :: Central TB Division. Available from: https://tbcindia.gov.in/index1.php?lang=1&level=1&sublinkid=4160&lid=2807
Shah MA, Shah I. Increasing Prevalence of Pediatric Drug-Resistant Tuberculosis in Mumbai, India and its Outcome. Pediatr Infect Dis J. 2018; 24(1).
Shet A, Sundaresan S, Forsberg BC. Pharmacy-based dispensing of antimicrobial agents without prescription in India: Appropriateness and cost burden in the private sector. Antimicrob Resist Infect Control. 2015;4(1).
Chaudhuri A. Recent changes in technical and operational guidelines for tuberculosis control programme in India - 2016: A paradigm shift in tuberculosis control. J Assoc Chest Physicians. 2017;5(1):1.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Bombay Hospital Journal

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.